Sang-Kyu Lee

Sang-Kyu Lee from Daejeon (KR) has applied for patents in technology areas such as C12N15/113, A61K9/00, A61P31/14 with BIONEER CORPORATION.

Patents

• [[BIONEER CORPORATION (20250066787). Composition for Administration of Double-Stranded Oligonucleotide Structures Using Ultrasonic Nebulizer for Prevention or Treatment of Respiratory Viral Infection Including COVID-19, Pulmonary Fibrosis Caused by Viral Infection, or Respiratory Diseases|Composition for Administration of Double-Stranded Oligonucleotide Structures Using Ultrasonic Nebulizer for Prevention or Treatment of Respiratory Viral Infection Including COVID-19, Pulmonary Fibrosis Caused by Viral Infection, or Respiratory Diseases (20250066787)]]